✦ LIBER ✦

30 A phase I clinical trial of HGS-ETR1, an agonist monoclonal antibody to TRAIL-R1, in patients with advanced solid tumors

✍ Scribed by R.B. Cohen; N.J. Meropol; K.M. Padavic; N.L. Fox; A. Corey; M. Fleming; M. Mita; M. Hill; E.K. Rowinsky; A. Tolcher

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

208 HGS-ETR1, a fully human monoclonal a

✍ S.J. Hotte; A.M. Oza; L.H. Le; M. MacLean; A. Iacobucci; A. Corey; N.L. Fox; H.W 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 151 KB

197 A phase I and pharmacokinetic (PK) s

✍ J. de Bono; G. Attard; R. Plummer; S. Pacey; C. Bale; L. Vidal; A. Greystoke; N. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 138 KB

P-460 Results of a phase 2 trial of HGS-

✍ Bonomi, P.; Greco, F.; Crawford, J.; Kelly, K.; Oh, Y.; Klein, J. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 150 KB

630 POSTER Results of a phase 2 study of

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB

A phase I study of the human monoclonal

✍ Weekes, Colin D.; Beeram, Muralidhar; Tolcher, Anthony W.; Papadopoulos, Kyriako 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 387 KB

202 POSTER Mapatumumab, a fully human ag

✍ C.H. Mom; S. Sleijfer; J.A. Gietema; N.L. Fox; C. Piganeau; L. Lo; D.R.A. Uges; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 60 KB